Evidence map›Paper›PMID 41680222›Full record

ArticleScientific data2026

Telomere to telomere level genome assembly of the Yarkand hare (Lepus yarkandensis).

Mengqi Xu, Yuge Cui, Hongcheng Kuang, Kai Wei, Wenjuan Shan

Abstract readDataset
In one paragraph

Article in Scientific data, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mengqi XuXinjiang Key Laboratory of Biological Resources and Genetic Engineering, College of Life Science and Technology, Xinjiang University, Urumqi, 830017, China.
Yuge CuiXinjiang Key Laboratory of Biological Resources and Genetic Engineering, College of Life Science and Technology, Xinjiang University, Urumqi, 830017, China.
Hongcheng KuangXinjiang Key Laboratory of Biological Resources and Genetic Engineering, College of Life Science and Technology, Xinjiang University, Urumqi, 830017, China.
Kai WeiXinjiang Key Laboratory of Biological Resources and Genetic Engineering, College of Life Science and Technology, Xinjiang University, Urumqi, 830017, China. kaiwei@xju.edu.cn.
Wenjuan ShanXinjiang Key Laboratory of Biological Resources and Genetic Engineering, College of Life Science and Technology, Xinjiang University, Urumqi, 830017, China. swj@xju.edu.cn.

Funding

National Natural Science Foundation of China (National Science Foundation of China) 32260116
6 · The paper itself

Abstract

The Yarkand hare (Lepus yarkandensis) is endemic to the Tarim Basin in Xinjiang, China. It is a key species and a critical component of the Tarim Basin ecosystems. However, the lack of a reference genome has hindered evolutionary and genetic studies of this species. Here, we assembled a telomere-to-telomere (T2T) genome of the Yarkand hare (LepYark_1.0) using PacBio HiFi, Nanopore, and Hi-C sequencing. The assembled genome size is approximately 2.70 Gb, with a scaffold N50 of 126.86 Mb. About 94.88% of the assembled sequences could be anchored to 24 pseudo-chromosomes, with a BUSCO assessment indicating a completeness of 99.0%. Repetitive sequences comprise 46.38% of the genome, with short interspersed nuclear elements (SINEs) accounting for the largest proportion. Additionally, we identified 24 centromeres and 46 telomeres. 32,298 protein-coding genes were annotated using de novo prediction and transcriptome data, functionally annotating 85% of them. This genome assembly provides genomic resources for studies on conservation, adaptive evolution and the exploration of genetic basis related to important traits of the Yarkand hare.

Indexed as

GenomeHaresTelomereAnimals

Identifiers

PMID41680222
PMCPMC13009506

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.